Gastrointestinal Stromal Tumors (GIST) research hub

A Phase II, single arm Study of avelumab in combination with Axitinib in Patients with unresectable/metastatic Gastrointestinal Stromal Tumor after failure of standard therapy - AXAGIST

This study looks at a new combination of two existing drugs, avelumab and axitinib, for people with a type of cancer called Gastrointestinal Stromal Tumor (GIST). It's for patients whose cancer has come back or spread after standard treatments haven't worked.

A Phase 1/2 Study of the Safety, Pharmacokinetics and Anti-Tumor Activity of the Oral KIT Inhibitor THE-630 in Patients with Advanced Gastrointestinal Stromal Tumors (GIST)